SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Clinical trial NCT04977024 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04977024
Sponsor: GeoVax, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Infection Hematopoietic and Lymphoid System Neoplasm Leukemia Lymphoma Plasma Cell Myeloma

Start date: 2021-09-27
Primary completion: 2026-12-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.